Q&A with TMB Expert Dr. Solange Peters

Using Deep Learning Systems to Radiologically Predict Pathologic Invasiveness in Lung Adenocarcinoma

PACIFIC Trial Leads to Durvalumab Approval in United States

Management of Pulmonary Nodules Detected by CT Screening

Barriers to Access to New Lung Cancer Drugs in Latin America

Q&A with the New IASLC President

Takeaways from KEYNOTE-021 and IMpower 150 on Combination Chemotherapy and Checkpoint Inhibition in NSCLC

Laurie E. Gaspar, MD, MBA

Radon: A Modifiable Lung Cancer Risk Factor

European Union Position Statement on Lung Cancer CT Screening: The Next 18 Months

The Upcoming Lung Cancer Neoadjuvant Meeting

Paolo Paoletti, MD